BUZZ-India's Lupin hits record high after buying Eli Lilly's diabetes drug

Shares of India's Lupin LUPN.NS rise 2.6% to a record high of 2370.6 rupees, in an otherwise weak broader market

LUPN among top pct gainers in the Nifty pharma index .NIPHARM, which is up 0.9%

Drugmaker buys diabetes drug Huminsulin in India from Eli Lilly LLY.N; no financials disclosed

Over 2 mln LUPN shares traded, over twice its 30-day avg

Analysts' avg rating on stock is "hold," same as for Dr Reddy's REDY.NS and Cipla CIPL.NS - LSEG

Their median PT on LUPN is 2259 rupees - LSEG

YTD stock has jumped 78% vs 39% gain in Nifty pharma

(Reporting by Aleef Jahan in Bengaluru)

((aleefjahan.cs@thomsonreuters.com;))